IMMUTEP Ltd Files Form 6-K
Ticker: PRRUF · Form: 6-K · Filed: Jul 3, 2024 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Jul 3, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, corporate-update, foreign-private-issuer
TL;DR
IMMUTEP Ltd (formerly Prima BioMed) filed a 6-K on July 3, 2024, updating its SEC information.
AI Summary
On July 3, 2024, IMMUTEP Ltd filed a Form 6-K. The company, previously known as Prima BioMed Ltd, is incorporated in Australia and operates in the Pharmaceutical Preparations sector. Its principal executive offices are located in Sydney, NSW.
Why It Matters
This filing provides an update on IMMUTEP Ltd's corporate status and regulatory filings with the SEC, which is important for investors tracking the company's compliance and reporting.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not contain significant new financial or operational information that would immediately impact risk.
Key Players & Entities
- IMMUTEP Ltd (company) — Registrant
- Prima BioMed Ltd (company) — Former company name
- July 3, 2024 (date) — Filing date
- 001-35428 (other) — SEC File Number
- Level 32, Australia Square 264 George Street, Sydney NSW 2000, Australia (location) — Principal executive office address
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, providing updates to the SEC.
When was this Form 6-K filed with the SEC?
The filing was made on July 3, 2024.
What was IMMUTEP Ltd's previous name?
IMMUTEP Ltd was formerly known as Prima BioMed Ltd.
Where are IMMUTEP Ltd's principal executive offices located?
Its principal executive offices are located at Level 32, Australia Square 264 George Street, Sydney NSW 2000, Australia.
Does IMMUTEP Ltd file its annual reports under Form 20-F or 40-F?
The registrant indicates it files annual reports under cover of Form 20-F.
Filing Stats: 263 words · 1 min read · ~1 pages · Grade level 17.4 · Accepted 2024-07-03 06:02:55
Filing Documents
- d845350d6k.htm (6-K) — 9KB
- d845350dex991.htm (EX-99.1) — 12KB
- g845350dsp4.jpg (GRAPHIC) — 9KB
- g845350dsp4a.jpg (GRAPHIC) — 5KB
- 0001193125-24-174612.txt ( ) — 42KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: July 3, 2024 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer